Read the quarter in context.
A source-linked quarter view: reported numbers, management language, guidance, and the risks that should carry forward.
ConCallIQ research layer
Signal, with the source still visible.
Use the controls below to narrow the view, then follow the evidence into the next layer of context.
Revenue
₹3,666 Cr
verified against source
Revenue YoY
—
reported change
EBITDA
Pending
latest reported figure
Source
screener in
record provenance
Actual signal trajectory
Where this quarter sits.
Quarter read
What the record says.
GCPL reported a steady quarter with India standalone volume growth of 7% and value growth of 7%, but EBITDA was flat due to high palm oil inflation. The company maintained A&P spend at 11.6% despite margin pressure, emphasizing quality over cost-cutting. International markets showed mixed performance: Indonesia delivered 7% volume growth and 17% EBITDA growth, while GAUM saw organic volume decline of 8% but EBITDA grew 33% as margins improved to 14.5%. LatAm rebounded strongly with 50% UVG and double-digit EBITDA margins. Management highlighted green shoots from the RNF molecule relaunch in HI, particularly in coils and incense sticks, but cautioned that electrics may take another quarter. Key risks include sustained palm oil inflation, urban GT slowdown, and competitive pressure in soaps from structuring technologies. The company expects volume growth to remain range-bound near high single digits for the next couple of quarters.
Colored figures show movement against the previous available record.
Guidance to track
- Management expects India standalone EBITDA margins to stay between 24% and 25% due to volatile palm oil prices, with no plans to cut media investments.
- The Raymond consumer portfolio EBITDA may be slightly below the promised 145-150 crore for the year due to distribution missteps in urban general trade.
- Management targets high single-digit volume growth for household insecticides, driven by RNF molecule rollout and distribution expansion.
- Africa EBITDA margins are expected to reach high teens, driven by supply chain efficiencies and stable macro conditions.
Risks flagged
- Sharp increase in palm oil and crude palm stearin prices due to import duties is pressuring margins, with sequential inflation of 25% on CPS.
- Urban general trade is under pressure from quick commerce disruption and consumption slowdown, which could impact distribution and sales.
- Raymond consumer portfolio may miss the 145-150 crore EBITDA target due to distribution issues in urban GT, though management expects only a slight shortfall.
- Market leader's adoption of bathing bar technology could widen price gap, though management believes quality focus will protect market share.
Key quotes
- We are not going to revisit this strategy now just because palm oil prices are inflated.
- We would rather drop EBITDA margin than cut media, because we know that EBITDA margin comes back, and then that media helps you in the long run on volume growth.
- In the case of incense stick, it's just a hard job of making sure that the product gets placed in an outlet.
Research modules